Picture of Atea Pharmaceuticals logo

AVIR — Atea Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Tang Capital Partners, LP- Concentra Sent Acquisition Proposal To Atea Pharmaceuticals With Terms To Acquire All Of Its Outstanding Common Stock

May 22 (Reuters) - Atea Pharmaceuticals Inc  AVIR.O :
    * TANG CAPITAL PARTNERS, LP-  CONCENTRA SENT ACQUISITION
PROPOSAL
TO ATEA PHARMACEUTICALS WITH TERMS TO ACQUIRE ALL OF ITS
OUTSTANDING COMMON STOCK
    * TANG CAPITAL PARTNERS, LP-  INTEND TO ENGAGE IN
DISCUSSIONS WITH
ATEA PHARMACEUTICALS AND ITS REPRESENTATIVES CONCERNING THE
ACQUISITION PROPOSAL
    * TANG CAPITAL PARTNERS, LP-  ACQUISITION PROPOSAL TO ATEA
PHARMACEUTICALS PROVIDES THAT IT IS NON-BINDING AND SUBJECT TO
CONFIRMATORY DILIGENCE

Source text for Eikon: [https://bit.ly/3Mqs0ds]
Further company coverage:  AVIR.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Atea Pharmaceuticals

See all news